Nuvaco 300 mg, 50 mg FC tablets
PDF Leaflet Revision Date: 23 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-1 infection in adults aged 18 years and older.
Dosage (summary)
One tablet daily for adults; not recommended for patients <18 years.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use during pregnancy may increase risk of neural tube defects; breastfeeding not recommended.
Key Drug Interactions
- Efavirenz
- Nevirapine
- Rifampicin
- Tipranavir
Contraindications
- Hypersensitivity
- Moderate and severe hepatic impairment
- Renal impairment
- Concomitant use with adefovir dipivoxil
Common side effects
- Fatigue
- Nausea
- Headache
- Rash
Counselling Points
- Monitor for signs of depression
- Avoid breastfeeding
- Discuss pregnancy risks with women of childbearing potential
Serious warnings
- Lactic acidosis
- Severe hepatomegaly
- Depression and suicidal ideation
Important Disclaimer
The Nuvaco 300 mg, 50 mg FC tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
